Quyen-Quyen Thuy Do

This inventor holds 9 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: Arena Pharmaceuticals, Inc., Cidara Therapeutics, Inc., Agouron Pharmaceuticals, Inc.. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Quyen-Quyen Thuy Do. Retrieved from https://idiyas.com/inventor/quyen-quyen-thuy-do

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 8)

% Patents Active = 88.9

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

6 out of 218

Arena Pharmaceuticals, Inc.

patents

2 out of 16

Cidara Therapeutics, Inc.

patents

1 out of 174

Agouron Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2005-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12569565 - COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS (2026-03-10),

2. 11987588 - Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto (2024-05-21),

3. 11833213 - Compositions and methods for the treatment of viral infections (2023-12-05),

4. 11560386 - Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto (2023-01-24),

5. 11339172 - Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto (2022-05-24),

6. 10927123 - Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto (2021-02-23),

7. 10662200 - Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto (2020-05-26),

8. 10479797 - Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto (2019-11-19),

9. 6903132 - Non-peptide GnRH agents, pharmaceutical compositions and methods for their use (2005-06-07),

Title: Quyen-Quyen Thuy Do: Innovator in Pharmaceutical Sciences

Introduction

Quyen-Quyen Thuy Do is a prominent inventor based in San Diego, CA, known for her significant contributions to pharmaceutical sciences. With a total of eight patents to her name, she has made remarkable advancements in the treatment of various medical conditions.

Latest Patents

Her latest patents include innovative compounds that serve as modulators of the beta-3 adrenergic receptor, which are useful for the treatment or prevention of heart failure and related disorders. These compounds are designed to modulate the activity of the beta-3 adrenergic receptor, providing new avenues for addressing heart-related health issues. Additionally, she has developed compositions and methods for the treatment of viral infections, which involve conjugates containing inhibitors of viral neuraminidase linked to various proteins. These conjugates are particularly effective in treating influenza viral infections.

Career Highlights

Throughout her career, Quyen-Quyen has worked with notable companies such as Arena Pharmaceuticals, Inc. and Cidara Therapeutics, Inc. Her work in these organizations has contributed to the development of groundbreaking therapies that address critical health challenges.

Collaborations

Quyen-Quyen has collaborated with talented individuals in her field, including Thuy-Anh Tran and Brett Ullman. These partnerships have fostered innovation and have been instrumental in advancing her research.

Conclusion

Quyen-Quyen Thuy Do exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents and collaborations continue to pave the way for new treatments and therapies that can significantly impact patient care.

Profile summary based on public USPTO records.